Comparing oxidative stress in type 1 diabetes and LADA
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at oxidative stress—a type of cell damage—in people with type 1 diabetes or LADA. It may help explain how these conditions affect the body and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes or LADA (latent autoimmune diabetes in adults).
- You are between 18 and 75 years old.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common liver fat build-up is in people with type 1 diabetes. It aims to understand what factors might increase the risk of liver problems.
This study uses artificial intelligence to analyze glucose monitor data from people with type 1 diabetes. The goal is to find patterns that could improve care and treatment.
This study looks at stored blood samples from adults with type 1 diabetes to understand how a protein called GLUT1 affects the immune system. The goal is to find new ways to control autoimmunity, which could lead to better treatments.
This study looks at fatty liver disease in adults with type 1 diabetes. It aims to understand how common it is and what factors might be linked, which could help improve care.
This trial studies people who develop severe, fast-onset “type 1 diabetes” with body-wide stress (ketosis/ketoacidosis) soon after symptoms start. It aims to better understand this condition and how to care for it early.
This trial tests a hybrid closed-loop insulin pump system for people with LADA (a slow-progressing form of autoimmune diabetes). It aims to see if the system can improve blood sugar control and reduce hypoglycemia.
Hear when a new Latent Autoimmune Diabetes in Adult (LADA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.